Drug Evaluation Committee Workshop "Smooth Submission of Electronic Data and Effective Utilization of CDISC Compliant Data" Presentation Material: Report on the Results of Questionnaire on "Inquiry Items for Electronic Data" and "Handling of Deviation Information and Case Acceptance/Rejection".

Aug 01, 2025

The Japan Pharmaceutical Manufacturers Association (JPMA) Committee on Drug Evaluation, Data Science Subcommittee, Task Force 3 has been working to promote smooth submission of electronic data and effective utilization of CDISC compliant data in light of the changing circumstances surrounding the submission of electronic data. As part of our activities, we will hold a workshop "Smooth Submission of Electronic Data for Applications and Effective Utilization of CDISC-compliant Data" in June 2025 for member companies of the Data Science Subcommittee as a place for those involved in electronic data submission to think about "how to implement the work smoothly" and exchange information on problems they encounter in their daily work. The workshop was held in June 2025 for member companies of the Data Science Subcommittee. We are pleased to present the following two presentations as a result of the task force at this meeting. We hope that these materials will be helpful for your information gathering and operations.

Share this page

TOP